Consumer Health News and Research

RSS

Out-of-pocket medical expenses to decline for most consumers under federal Affordable Care Act

Out-of-pocket medical expenses will decline for most consumers who become newly insured or change their source of health insurance under the federal Affordable Care Act, according to a new RAND Corporation study.

2 Oct 2013

Innovative packaging design aids convergence in the pharmaceutical industry

PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical trials services, announces the availability of a white paper detailing how it’s innovative packaging design aids convergence in the pharmaceutical industry.

30 Sep 2013

Colorado continues preparing for exchange 'snafus'; abortion coverage questions persist for Washington's marketplace

Meanwhile, researchers say that if Connecticut's streamlined enrollment process works well, it could mean a significant jump in the number of people who gain insurance for the first time.

30 Aug 2013

Viewpoints: GOP trapped between angry base and reality of health law; small businesses 'scrambling;' competing views of Medicaid expansion in Va.

Recent political reporting suggests that Republican leaders are in a state of high anxiety, trapped between an angry base that still views Obamacare as the moral equivalent of slavery and the reality that health reform is the law of the land and is going to happen (Paul Krugman, 8/18).

20 Aug 2013

Moberg Pharma granted exclusive rights to market Kerasal Nail in China

Moberg Pharma AB today announced that Menarini Asia-Pacific, a member of the Menarini Group - a top 40 global pharmaceutical company - has been granted the exclusive rights to market and sell Kerasal Nail in China. The companies now intend to seek marketing authorization for the product in the Chinese market.

22 Jul 2013

Pfizer announces approval of tofacitinib for treatment of rheumatoid arthritis

Pfizer Inc. announced today that tofacitinib has been approved for the treatment of rheumatoid arthritis in patients who had an inadequate response to existing therapies in several additional countries around the world, including Switzerland, which is the first European country to receive approval.

15 Jul 2013

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.

11 Jul 2013

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

10 Jul 2013

Elcelyx's study shows NewMet has better glucose-lowering effects than metformin in type2 diabetic patients

Elcelyx Therapeutics announced today that clinical study results confirm that the primary site of action of Type 2 diabetes medicine metformin is in the lower bowel rather than in the circulation.

24 Jun 2013

Calif. regulator seeks to bar Anthem from small business health exchange

Meanwhile, Minnesota officials announce the opening of a call center Sept. 3 to answer consumer questions about the state's online insurance marketplace, which will begin enrolling people a month later.

15 Jun 2013

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to NewMet, a delayed-release formulation of generic metformin, at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL.

15 Jun 2013

No easy answers about health law's impact on full-time jobs

CQ Health Beat parses conflicting data on whether the health law may be spurring employers to keep workers part-time. Meanwhile, Sen. Orrin Hatch, R-Utah, questions whether the projections of rising health insurance subsidy costs may be due to employers dumping coverage. News outlets also offer reports on health exchanges from Connecticut, Maryland, Colorado and California.

7 Jun 2013

At the Florida State House, Medicaid expansion drama continues

News outlets also detail the latest expansion news from Oklahoma, Iowa, Georgia, Louisiana, Maine and Arizona.

2 May 2013

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.

From Pfizer, Inc. 30 Apr 2013

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.

From Pfizer, Inc. 29 Apr 2013

Ohio Gov. vows to keep trying on Medicaid expansion; Ark. lawmakers near key votes on issue

The Ohio House is dropping expansion from Gov. John Kasich's budget while he says hospitals and other stakeholders must help in the effort to expand the health care program for low-income people. Meanwhile, supporters of an expansion try to rally support in Arkansas.

12 Apr 2013

Consumer Health News and Research

Out-of-pocket medical expenses to decline for most consumers under federal Affordable Care Act

Innovative packaging design aids convergence in the pharmaceutical industry

Colorado continues preparing for exchange 'snafus'; abortion coverage questions persist for Washington's marketplace

Viewpoints: GOP trapped between angry base and reality of health law; small businesses 'scrambling;' competing views of Medicaid expansion in Va.

Moberg Pharma granted exclusive rights to market Kerasal Nail in China

Pfizer announces approval of tofacitinib for treatment of rheumatoid arthritis

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Elcelyx's study shows NewMet has better glucose-lowering effects than metformin in type2 diabetic patients

Calif. regulator seeks to bar Anthem from small business health exchange

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

No easy answers about health law's impact on full-time jobs

At the Florida State House, Medicaid expansion drama continues

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Ohio Gov. vows to keep trying on Medicaid expansion; Ark. lawmakers near key votes on issue

CHOP, Pfizer join forces to expedite novel treatments for children

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Radial forearm free flap shows worth in mandibular reconstruction

Learned helplessness role in inflammatory polyarthritis revealed

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News